|
|
Volumn 364, Issue 1, 2011, Pages 83-84
|
|
Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METHOTREXATE;
PROTEIN TYROSINE KINASE INHIBITOR;
ANTIRHEUMATIC AGENT;
OXAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN KINASE SYK;
PROTEIN TYROSINE KINASE;
PYRIDINE DERIVATIVE;
R788 COMPOUND;
SIGNAL PEPTIDE;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
JOINT SWELLING;
LETTER;
LONG TERM CARE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
DRUG ANTAGONISM;
DRUG COMBINATION;
NOTE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG THERAPY, COMBINATION;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
METHOTREXATE;
OXAZINES;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIDINES;
|
|
EID: 78650913893
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1012187 Document Type: Letter |
|
Times cited : (5)
|
|
References (1)
|
